Dr. Reddy's signs multi-country deal for gastroenterology in India & select Emerging Markets
Pharma | News | 0 Comment | 19 May, 2022
Indian firm Dr. Reddy’s Laboratories has entered into an exclusive partnership with South Korea-based HK inno.N Co...Read more
Kyowa Kirin to build new biopharma API building
Pharma | News | 0 Comment | 20 May, 2022
Japanese firm Kyowa Kirin has decided to build a new active pharmaceutical ingredient (API) manufacturing building (HB7 ...Read more
Vetter Achieves a Three-Peat in Winning the Best Managed Companies Award
Pharma | News | 0 Comment | 18 May, 2022
Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family (second from left) along with ...Read more
UK-based Croda announces new pharma business
Pharma | News | 0 Comment | 18 May, 2022
UK-based Croda has announced that its Health Care division will now become Croda Pharma, bringing its core speciality ex...Read more
US FDA approves Lilly's COVID-19 drug
Pharma | News | 0 Comment | 16 May, 2022
Eli Lilly and Company and Incyte have announced that the U.S. Food and Drug Administration (FDA) has approved OLUMIANT&n...Read more
Novo Holdings, Shionogi offer treatment for invasive fungal infections in Europe and Asia
Pharma | News | 0 Comment | 16 May, 2022
Novo Holdings has announced that its portfolio company F2G has entered into a strategic collaboration with Japan-based S...Read more
WODA combining forces to reach patients with rare diseases across globe
Pharma | News | 0 Comment | 13 May, 2022
EffRx Pharmaceuticals, Medis, Orpharm, OrphanDC, and Vector Pharma, announced the newly formed World Orphan Drug Allianc...Read more
Taiwan strengthens treatment offering for inflammation and pain after cataract surgery
Pharma | News | 0 Comment | 13 May, 2022
Taiwan-based Formosa Pharmaceuticals and AimMax Therapeutics have reported successful top-line results from CPN-301, the...Read more
Aravax appoints Dr Brett Haumann to Board of Directors
Pharma | News | 0 Comment | 11 May, 2022
Australia's Aravax, a clinical stage biotechnology company focused on developing the most advanced novel therapy for pea...Read more
Immuron appoints Steven Lydeamore as Chief Executive Officer
Pharma | News | 0 Comment | 06 May, 2022
Immuron Limited, an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeuti...Read more
Orion partners with Jemincare for novel non-opioid drug candidate for pain treatment
Pharma | News | 0 Comment | 06 May, 2022
Finland's Orion Corporation has entered into an agreement with Chinese Jemincare, through which Orion will receive exclu...Read more
5 Transformative Merits of Blockchain in Pharma
Pharma | Analysis | By Ayesha Siddiqui | 0 Comment | 06 May, 2022
Blockchain - an open, decentralised, secure, public ledger and the technology behind crypto currencies like bitcoin and ...Read more
EyePoint Pharma with Betta Pharma lay focus on eye diseases across the globe
Pharma | News | 0 Comment | 05 May, 2022
EyePoint Pharmaceuticals has announced the execution of a license agreement with Betta Pharmaceuticals to develop and co...Read more
Jazz Pharma and Sumitomo Pharma to develop therapies for sleep disorders
Pharma | News | 0 Comment | 05 May, 2022
Ireland-based Jazz Pharmaceuticals and Sumitomo Pharma Co. in Japan, have entered into an exclusive licensing agree...Read more
NiKang Therapeutics, Hansoh Pharma ink $200M worth deal for cancer treatment in Greater China
Pharma | News | 0 Comment | 04 May, 2022
NiKang Therapeutics , a clinical stage biotech company focused on developing innovative small molecule oncology medicine...Read more
Servatus strengthens board with new appointment
Pharma | News | 0 Comment | 04 May, 2022
Servatus Limited, an Australian biopharmaceutical company delivering leading novel autoimmune and microbiome therapies, ...Read more
Incyte and Maruho lay focus on inflammatory dermatologic diseases in Japan
Pharma | News | 0 Comment | 03 May, 2022
Incyte and Maruho Co., Ltd. have announced that the companies have entered into a Strategic Alliance Agreement for the d...Read more
Visirna brings RNAi therapeutics for cardiovascular & metabolic diseases in Greater China
Pharma | News | 0 Comment | 29 Apr, 2022
US-based Arrowhead Pharmaceuticals, Inc. has formed a joint venture, Visirna Therapeutics, with Vivo Capital t...Read more